Pharm-ERA

Improving monitoring and environmental risk assessment of pharmaceuticals, antimicrobial resistance and pathogens from terrestrial to aquatic environments

Protecting our planet against pharmaceutical pollution

The contamination of global soil and aquatic ecosystems by pharmaceuticals, antimicrobial-resistant microorganisms, and pathogens is a pressing concern, threatening both our environment and human well-being. With the support of the Marie Skłodowska-Curie Actions programme, the Pharm-ERA project brings together academics, public and private stakeholders, and EU policymakers to address this urgent issue. With 10 doctoral projects spanning scientific disciplines such as environmental chemistry, ecotoxicology, microbial ecology, molecular biology and modelling, Pharm-ERA seeks to develop innovative solutions and improve monitoring techniques and environmental risk assessment. The ultimate aim is to protect the diversity and functions of microbial life in contaminated ecosystems while ensuring the sustainability of our planet and promoting human and animal health.

3I consortium
article

02 July 2025

By: Emilie EGEA

Two External Perspectives on the Pharm-ERA Summer School Experience

The 2025 Pharm-ERA Summer School welcomed participants from across Europe and beyond. Among the attendees were two external PhD students, Harriet from the UK and Wissam from Algeria, who kindly shared their impressions of this enriching week of scientific training, exchange, and collaboration.

From June 16th to 20th, 2025, the Pharm-ERA Doctoral Network consortium organised its Summer School “Theory and practice in environmental chemistry, ecotoxicology and risk assessment: Transfer from science to end-users”, bringing together a rich and diverse community of researchers, experts, and early-stage scientists.

Theory and practice in environmental chemistry, ecotoxicology and risk assessment: Transfer from science to end-users 16-20 June 2025 - AquaBioTech Group (Malta)

This event showcased the progress made by the 10 Pharm-ERA Doctoral candidates and generated rish and promising scientific exchanges.